The price of Asensus Surgical Inc (AMEX: ASXC) closed at $0.24 in the last session, down -14.25% from day before closing price of $0.28. In other words, the price has decreased by -$0.0399 from its previous closing price. On the day, 3701357 shares were traded.
Ratios:
We take a closer look at ASXC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.31 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.14.
On September 08, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $1.50.
On May 26, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $4.H.C. Wainwright initiated its Buy rating on May 26, 2021, with a $4 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 14 ’23 when Starling William N JR bought 18,134 shares for $0.28 per share. The transaction valued at 5,078 led to the insider holds 39,134 shares of the business.
Starling William N JR sold 18,134 shares of ASXC for $5,078 on Dec 14 ’23. The Director now owns 0 shares after completing the transaction at $0.28 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASXC now has a Market Capitalization of 65.30M and an Enterprise Value of 49.92M. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.61 while its Price-to-Book (P/B) ratio in mrq is 1.90. Its current Enterprise Value per Revenue stands at 8.90 whereas that against EBITDA is -0.66.
Stock Price History:
Over the past 52 weeks, ASXC has reached a high of $0.86, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is 0.2896, while the 200-Day Moving Average is calculated to be 0.3236.
Shares Statistics:
According to the various share statistics, ASXC traded on average about 1.17M shares per day over the past 3-months and 1.27M shares per day over the past 10 days. A total of 271.99M shares are outstanding, with a floating share count of 266.52M. Insiders hold about 2.01% of the company’s shares, while institutions hold 9.68% stake in the company. Shares short for ASXC as of Feb 29, 2024 were 17.6M with a Short Ratio of 14.99, compared to 17.51M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.64% and a Short% of Float of 6.76%.
Earnings Estimates
The company has 1 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.05 for the current quarter, with a high estimate of -$0.05 and a low estimate of -$0.05, while EPS last year was -$0.09. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.19 and -$0.19 for the fiscal current year, implying an average EPS of -$0.19. EPS for the following year is -$0.17, with 1 analysts recommending between -$0.17 and -$0.17.
Revenue Estimates
According to 1 analysts, the current quarter’s revenue is expected to be $1.5M. It ranges from a high estimate of $1.5M to a low estimate of $1.5M. As of the current estimate, Asensus Surgical Inc’s year-ago sales were $976k, an estimated increase of 53.70% from the year-ago figure.
A total of 1 analysts have provided revenue estimates for ASXC’s current fiscal year. The highest revenue estimate was $11.8M, while the lowest revenue estimate was $11.8M, resulting in an average revenue estimate of $11.8M. In the same quarter a year ago, actual revenue was $8.58M, up 37.60% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $13.9M in the next fiscal year. The high estimate is $13.9M and the low estimate is $13.9M. The average revenue growth estimate for next year is up 17.80% from the average revenue estimate for this year.
